The major players in the market are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, Boehringer Ingelheim International GmbH, Merck & Co
Stremming J, White A, Donthi A, Batt DG, Hetrick B, Chang EI, Wesolowski SR, Seefeldt MB, McCurdy CE, Rozance PJ and Brown LD (2022) Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheep
GlaxoSmithKline cited commercial reasons (poor market uptake compared to Trulicity and Ozempic)
Dietary and endogenous enzymatic and nonenzymatic antioxidants counteract the damaging effects of free radicals by various mechanisms, such as electron donation, catalytic removal, or binding radicals and/or gene expression regulation
Only medullary thyroid carcinoma and MEN2 syndrome prevent GLP-1 use